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Abstract
Background: Chronic low back pain (CLBP) experienced in middle-age may have important implications for
vertebral bone health, although this issue has not been investigated as a primary aim previously. This study
investigated the associations between CLBP and dual energy X-ray absorptiometry (DXA)-derived vertebral bone
mineral measures acquired from postero-anterior and lateral-projections, among community-dwelling, middle-aged
adults.
Methods: Twenty-nine adults with CLBP (11 male, 18 female) and 42 adults with no history of LBP in the
preceding year (17 male, 25 female) were evaluated. Self-reported demographic and clinical data were collected via
questionnaires. Areal bone mineral density (aBMD) was measured in the lumbar spine by DXA. Apparent volumetric
(ap.v) BMD in the lumbar spine was also calculated. Multiple linear regression models were used to examine
associations between study group (CLBP and control) and vertebral DXA variables by gender, adjusting for height,
mass and age.
Results: There was no difference between groups by gender in anthropometrics or clinical characteristics. In the
CLBP group, the mean (SD) duration of CLBP was 13.3 (10.4) years in males and 11.6 (9.9) years in females, with
Oswestry Disability Index scores of 16.2 (8.7)% and 15.4 (9.1)%, respectively. Males with CLBP had significantly lower
adjusted lateral-projection aBMD and lateral-projection ap.vBMD than controls at L3 with mean differences
(standard error) of 0.09 (0.04) g/cm2 (p = 0.03) and 0.02 (0.01) g/cm3 (p = 0.04). These multivariate models
accounted for 55% and 53% of the variance in lateral-projection L3 aBMD and lateral-projection L3 ap.vBMD.
Conclusions: CLBP in males is associated with some lumbar vertebral BMD measures, raising important questions
about the mechanism and potential clinical impact of this association.

Background
Maximising peak bone mass towards late adolescence
and minimising bone loss after this period are important
factors in the maintenance of optimal skeletal integrity.
Although a large volume of research has been dedicated
to minimising bone loss towards later adulthood, particularly in the context of age-related and post-menopausal
osteoporosis, maintenance of bone strength at earlier life
stages is equally, if not more important, from a lifecourse
perspective. Therefore, a better understanding of the
potentially-modifiable events across the lifecourse which
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may be associated with sub-maximal bone accretion or
influence bone loss is important, particularly when considering the immense population burden of bone fragility.
Low back pain (LBP) is one of the most common and
significant musculoskeletal disorders experienced across
the lifecourse and is most common during middle-age [1].
It represents an enormous public health issue worldwide
owing to the soaring healthcare costs associated with the
condition and the societal and personal burdens imposed
[2]. The lifetime prevalence of LBP is around 80% for
adults [3] and adolescents [4] and although in the majority
of cases the experience of LBP is benign and most people
regain functional capacity, pain and disability can persist
[5]. For a proportion of individuals (approximately 1020%) the experience of LBP persists beyond three months
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to become chronic, experienced as either a continuous or
episodic course of pain [6]. In many such cases, chronic
LBP (CLBP) is associated with a myriad of biopsychosocial
factors which may also have implications for bone health
[7].
A relationship between impaired bone health and back
pain is well established in conditions such as osteoporosis, osteoarthritis and inflammatory arthritis. In these
circumstances, the association between back pain and
bone health may be mediated by vertebral fracture [8],
hyperkyphosis [9], inflammation and joint degeneration
[10] and intervertebral disc degeneration [11]. However,
skeletal integrity is rarely considered in the context of
non-specific CLBP experienced during middle-age,
despite some evidence for an association between back
pain and impaired bone health outside the context of
age-related osteoporosis and osteoporotic vertebral fractures [7]. Further, although co-morbid conditions are
common among individuals with LBP, impaired bone
health as a co-morbidity associated with LBP has not
been examined outside older age groups. Our recent
review summarised the likely genetic and environmental
mechanisms and evidence underlying an association
between bone health and LBP [7]. For example, longitudinal data demonstrate the association between cumulative physical activity and bone mass [12], yet the
experience of CLBP is often associated with physical disability and reduced vigorous physical activity [13] which
are likely to decrease the normal physiologic loads
transferred to bone tissue through a de-conditioning
syndrome.
Few studies in that review were designed with a primary aim of examining the association between back
pain and bone health in middle-aged, healthy adults.
Although some evidence for an association between back
pain and impaired bone health was identified, comparability between the studies to define a web of evidence
was limited due to poor characterisation of LBP amongst
the cohorts described, particularly with respect to pain
duration, severity and disability. Many inconsistencies in
the bone densitometry methods used were also identified
as limitations in the literature [7]. For example, bone
health is unlikely to be influenced by non-chronic LBP
episodes (< 3 months duration) and this may be one reason why studies which examine cohorts with a point prevalence of LBP are unable to establish a relationship
between bone density and LBP. Further, the skeletal
implications of LBP are likely to be site-specific for a
range of reasons including the unique trunk movement
patterns adopted by individuals with CLBP, intervertebral
disc degeneration and local inflammation. Measurement
of bone mineral parameters at non-vertebral sites is
therefore less likely to uncover a relationship between
bone health and back pain.
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Dual energy X-ray absorptiometry (DXA) is the most
common clinical tool used to measure areal bone mineral
density (aBMD), an accepted surrogate for bone strength.
In the context of CLBP, lateral-projection DXA may be a
more appropriate method to measure vertebral bone
mineral than postero-anterior (PA) projection DXA. The
use of lateral-projection DXA reduces the potentially
over-riding influence of spinal degenerative conditions,
which elevate the proportion of non-trabecular bone tissue, and isolates the metabolically active trabecular bone
of interest from the cortical elements of the vertebral
body [14]. Further, more precise measures of vertebral
depth are possible using lateral-projection techniques,
from which apparent volumetric vertebral bone mineral
density (ap.vBMD) can be calculated, and these address
some of the comparability issues associated with areal
measures. Therefore, the aim of this study was to examine the association between vertebral bone mineral measures acquired using lateral-projection DXA and CLBP in
a population of middle-aged adults.

Methods
Participants

Participants in the study represent a subset of the Joondalup Spinal Health Study (JSHS) cohort. Approval to conduct the JSHS was granted by Curtin University and Edith
Cowan University Human Research Ethics Committees
and all participants provided written, informed consent.
The JSHS is a community-based cohort study which
aims to explore familial aspects in spinal pain presentations by studying families where no member reported a
history of LBP in the previous 12 months (control families)
and families where at least one parent and one child
reported chronic (≥ 3 months duration either continuously, or intermittently such that pain was experienced at
least once per week), disabling LBP within the past month
(pain families). ‘Disabling LBP’ was defined as pain impacting on at least 3 of the following areas: lifting, walking, sitting, sleeping, social interaction, travel, need to take
medication, need to see a health professional, consistent
with an earlier study [15]. A total of 231 participants were
recruited for the JSHS for which full datasets were available for 227 (98.3%) participants. A detailed description of
the JSHS and the recruitment method has been reported
previously [15].
The sample for the current study was derived from adult
participants (N = 151) within the JSHS cohort. The subgroup for this study was generated after several exclusion
criteria were applied based on historical risk factors for
osteoporosis. These risk factors were assessed via questionnaire, completed by each participant independently at
home, in order to minimise the potential confounding
effects on DXA measures. This resulted in a final sample
size of 29 adults with disabling CLBP and 42 adults with
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no history of LBP in the last 12 months (N = 71). These
criteria for exclusion and the number of participants
excluded (n) were:
• Aged greater than 60 years to minimise the potential
effect of age-related bone loss and spinal degenerative
conditions (n = 3 excluded).
• Currently smoking on all or most days or a history
of smoking on all or most days in the last 10 years (n =
20 excluded).
• A period of immobilisation of ≥ 6 weeks within the
last 12 months to minimise the deleterious effects of
immobilisation on bone mass (n = 4 excluded).
• Health conditions known to affect aBMD other than
primary osteoporosis and osteopenia (rheumatoid arthritis, osteomalacia, Padget’s disease, Cushing’s syndrome,
ankylosing spondylitis) to exclude the influence of comorbidities on aBMD (n = 3 excluded: rheumatoid
arthritis [n = 2] and osteomalacia [n = 1]).
• Medications known to affect aBMD (oestrogen, progesterone, bisphosphonates and other osteoporosis
therapies) which have been taken for ≥ 6 months to
exclude pharmacologically-mediated effects on bone
(n = 1 excluded).
• Menarche delayed beyond 16 years of age, cessation
of normal menstrual periods prior to the age of 45
other than cases of hysterectomy and women more than
5 years post menopause to exclude the potential deleterious effect of reduced circulating oestrogen on aBMD
(n = 4 excluded).
• Adults recruited in the JSHS who failed to meet
inclusion criteria for CLBP or control groups (n = 24
excluded).
• Body mass index (BMI) < 18 or > 30 to exclude the
influence of low body weight and obesity on aBMD
measures and accuracy of densitometer performance
(n = 21 excluded).
Questionnaire data

Demographic and clinical characteristics related to LBP
were collected via questionnaires, completed independently by each participant. All participants responded to
the modified Nordic Musculoskeletal Pain Questionnaire
to ascertain the presence and duration of LBP [16]. Psychological wellbeing was measured using the 21-item
Depression Anxiety and Stress Scale (DASS-21) [17]. The
psychological correlates of CLBP including depression,
anxiety and stress have been linked to reduced bone density and reduced bone turnover among pre-, peri-and
postmenopausal women [18]. The DASS-21 has three
sub-scales (depression, stress and anxiety) each consisting
of seven items measured on a 4-point scale (0-did not
apply to me at all, to 3-applied to me very much or most
of the time). The internal consistency (a = 0.92-0.95) and
reliability (r = 0.65-0.78) of the DASS-21 have been
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established previously [19]. The volume of weekly, nonwork-related vigorous physical activity of at least 10 min
duration was assessed using a standard question from the
International Physical Activity Questionnaire [20]. All participants indicated whether they were currently taking
analgesic or non-steroidal anti-inflammatory medications.
Participants who reported currently experiencing CLBP
(pain duration of ≥ 3 months) responded to additional
pain-specific questions to characterise the nature of their
pain. LBP intensity in the past week was quantified with a
numeric pain rating scale (0-10 where 0 = no pain and
10 = extreme pain). The personal impact of LBP was measured by asking the participants to indicate the number of
LBP episodes in the last year (1-3, 4-10, > 10 episodes),
number of work days missed in the last year (0, 1-2, 3-7,
15-30, 181-365 days), and any interference with normal
daily activities and recreational activities (yes/no). LBPrelated disability was measured with the Oswestry Disability Index (ODI) [21]. The ODI contains 10 questions, each
with six ordinal responses scored as 0-5. The total score is
expressed as a percentage with a higher score representing
higher disability. Internal consistency (Cronbach’s alpha
(a)) of the ODI in adults is reported to range from a =
0.71-0.87 [21].
Physical data

Anthropometric and other physical characteristics were
measured in a standardised fashion and in a random
order in a University laboratory by trained research officers. Height (cm) was measured for each participant
without shoes using a standing stadiometer while mass
(kg) was measured using electronic scales. The height
and mass data were used to calculate BMI (kg/m2). Hip
and waist girths (cm) were measured using body girth
measuring tapes. Measurement of back muscle endurance (BME) was performed using the Biering-Sorenson
test [22]. The test requires participants to hold their
trunk horizontal in a prone position unsupported for a
maximum of 360 s, while the pelvis and lower limbs
remain supported on a plinth. Moderate-high reliability
(r = 0.66-0.98), in both LBP and non-LBP populations,
has been reported [23]. A Hologic Discovery A densitometer (Hologic, Inc, Bedford, MA, USA) was used to
measure bone mineral content (BMC) (g) and aBMD (g/
cm 2 ) in lumbar spine. Apparent volumetric BMD (ap.
vBMD) (g/cm3) was also measured in the lumbar spine
using the vertebral width-adjustment feature of the Hologic analysis software version 12.4:3. The lumbar spine
was scanned with a matched PA-lateral scan sequence in
high-definition mode using the rotating C-arm feature of
the densitometer. All participants lay supine on the scanner bed with hips and knees flexed to 90°, supported by a
Hologic positioning device. The upper limbs remained
elevated with palms resting behind the back of the head.
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Analysis of the scans was performed using the automated
method with Hologic analysis software version 12.4:3.
The L3 vertebra was chosen as the level of interest since
previous work suggests that precision of densitometric
parameters is maximised at this level [24]. Further, the
potentially over-riding influence of the ribs and ilia at L2
and L4, respectively, are overcome by measuring properties at L3 in isolation. DXA variables of interest included
L3 BMC (PA and lateral projection), L3 aBMD (PA and
lateral projection), total spine BMC and aBMD (PA projection), and L3 width-adjusted ap.vBMD (lateral projection). The T-scores for the PA-projection total spine
parameters were also acquired. Quality control of the
scanner was monitored by regularly scanning a Hologic
phantom. All scanning and analysis was performed by
one of three trained research officers. The reliability of
performing PA and lateral scanning of the lumbar spine
has been established previously [24,25]. The reproducibility of DXA parameters for densitometer used in the
laboratory has been established previously with data from
a pilot study for PA-projection aBMD in the lumbar
spine indicating excellent short-term reproducibility (%
CV: 1.1%).
Data analysis

Questionnaire-derived and physical characteristics were
compared between the CLBP groups and genders using ttests for continuous data and chi square tests for categorical data. Univariate linear regression models were used to
examine the association between vertebral DXA variables
and predictor variables including the DASS-21 scores,
volume of physical activity and back muscle endurance for
males and females separately. Subsequently, multiple linear regression models were used to examine the association between study group (CLBP and no LBP) and
vertebral DXA-derived variables using the ‘enter’ method.
Separate models were run for each DXA variable of interest and for each gender. The DXA-variables were defined
as the dependent variable for each model while ‘group’
was defined as a dichotomous predictor variable. Each
model also included height, mass and age as constant predictor variables so that any association between a given
DXA variable and group was adjusted for these factors
which are known to influence BMC and aBMD values.
Predictor variables identified as significantly-associated
with DXA variables in the univariate analyses were also
included in the multivariate models. The regression coefficient (B) in each multivariate model represents the mean
difference in each DXA variable between groups, adjusted
for age, height and mass and other predictor variables.
The proportion of variance in each DXA variable
accounted for by all the predictor variables in each model
was expressed with an R2 value. Data were analysed SPSS
Statistics version 17.0 (SPSS, Inc).
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Results
Demographic and clinical characteristics

The demographic and clinical characteristics and unadjusted DXA-derived parameters of both groups are summarised in Table 1. In both groups, males were
significantly heavier, taller and had a greater waist girth
than females. Females with CLBP had significantly lower
BME than females without CLBP. There were no other
within-group or between-group differences in other demographic or clinical variables. As expected, in both groups
males had significantly greater unadjusted total spine
BMC, and PA-projection L3 BMC than females (p < 0.05).
In the no-LBP group, males also had significantly greater
lateral-projection L3 BMC than females (p < 0.05). Tscores across the cohort for the males and females ranged
from -2.3 - 1.5 and -2.5 - 3.8, respectively.
Univariate associations

In males, the predictor variables (DASS-21 scores, volume
of physical activity and back muscle endurance) were not
significantly associated with the DXA variables (PA L3
BMC, PA L3 aBMD, PA total spine BMC, PA total spine
aBMD, lateral L3 BMC, lateral L3 aBMD, lateral L3 ap.
vBMD) in univariate models (r2 = 0-0.09, p = 0.13-0.99).
Among females, a significant association was identified
between vigorous physical activity and lateral-projection
L3 variables (lateral L3 aBMD: r2 = 0.11, p = 0.04; lateral
L3 ap.vBMD: r2 = 0.10, p = 0.04), but no other predictor
variables (r2 = 0-0.06, p = 0.14-0.97).
Multivariate associations

Multivariate models including the predictor variables
CLBP, age, height and mass (and physical activity for
some female models) explained between 47 and 55% and
25-35% of the variance in vertebral DXA variables in
males and females, respectively (Table 2). A significant
association of CLBP with both aBMD and ap.vBMD at
L3 measured with lateral-projection DXA was identified
in males independent of age, height and mass (Table 2).
This association was not observed for DXA-parameters
acquired from a PA-projection scan, nor among females.
Males with CLBP had significantly lower aBMD and ap.
vBMD at L3 compared to males without LBP, with a
mean difference (standard error) of 0.09 (0.04) g/cm2 and
0.02 (0.01) g/cm3, respectively, when adjusted for covariates. The regression models accounted for 55% and 53%
of the variance in lateral-projection aBMD and ap.vBMD
at L3, respectively for males. Figures 1 and 2 illustrate the
unadjusted L3 aBMD and ap.vBMD, respectively, for
males with and without CLBP.

Discussion
CLBP in males was associated with reduced vertebral
bone mineral measures acquired through lateral-

No-LBP group

CLBP group

Characteristic

male

female

gender mean difference (95%
CI)

N (%)

17 (40.5)

25 (59.5)

Age (years)

35.8 (14.0)

36.2 (12.0)

-0.3 (-8.5,7.8)

Height (cm)

179.3 (7.1)

163.4 (7.7)

Mass (kg)

79.1 (13.1)

61.8 (10.4)

BMI (kg/m2)

24.5 (3.1)

Hip girth (cm)

male

female

11 (37.9)

18 (62.1)

Mean difference (95% CI)
between groups
gender mean
difference (95%
CI)

Male

female

36.2 (15.4) 34.7 (14.3)

1.5 (-10.1, 13.0)

-0.4 (-11.9, 11.2) 1.4 (-6.7, 9.6)

15.9 (11.6, 20.6)*

177.6 (4.4) 165.1 (6.0)

12.5 (8.2, 16.8)*

1.7 (-3.2, 6.6)

17.3 (10.0, 24.6)*

81.3 (8.1)

66.3 (9.1)

15.0 (8.1, 21.9)*

-2.2 (-11.3, 6.9)

-4.5 (-10.7, 1.6)

23.1 (3.0)

1.4 (-0.5, 3.4)

25.8 (2.7)

24.3 (3.0)

1.5 (-0.8, 3.8)

-1.3 (-3.6, 1.1)

-1.2 (-3.1, 0.6)

98.4 (7.2)

96.1 (9.3)

2.3 (-3.1, 7.7)

101.3 (6.2) 100.4 (7.1)

0.9 (-4.5, 6.2)

-2.8 (-8.2, 2.6)

-4.3 (-9.5, 1.0)

Waist girth (cm)

84.4 (8.6)

73.2 (10.3)

11.2 (5.2, 17.4)*

86.6 (8.5)

76.2 (9.3)

10.4 (3.3, 17.4)*

-2.3 (-9.0, 4.6)

-3.1 (-9.3, 3.1)

Back muscle endurance (sec) [range 0-360]

188.8 (49.9) 216.4 (92.6) -27.6 (-77.4, 22.2)

165.3
(51.9)

148.6 (72.9) 16.7 (-35.1, 68.4)

23.5 (-16.8, 63.8) 67.8 (14.7, 120.8)
*

DASS-21 depression [range 0-21]

2.1 (3.8)

2.8 (5.6)

-0.7 (-3.9, 2.4)

4.2 (6.7)

2.1 (2.4)

2.2 (-1.4, 5.7)

-2.2 (-6.3, 1.9)

DASS-21 anxiety [range 0-21]

1.8 (2.3)

2.5 (4.6)

-0.7 (-3.2, 1.7)

2.9 (2.7)

3.1 (3.4)

-0.2 (-2.7, 2.3)

-1.1 (-3.1, 0.8)

-0.6 (-3.2, 1.9)

DASS-21 stress [range 0-21]

8.7 (7.4)

10.1 (7.0)

-1.4 (-5.9, 3.2)

6.5 (6.2)

8.8 (4.9)

-2.2 (-6.5, 2.0)

2.2 (-3.4, 7.7)

1.3 (-2.6, 5.2)

Days/week of vigorous physical activity (days) [range
0-7]

4.1 (1.9)

3.4 (3.4)

0.8 (-0.3, 1.8)

3.6 (2.3)

3.1 (1.4)

0.4 (-1.0, 1.8)

0.6 (-1.1, 2.2)

0.2 (-0.7, 1.2)

ODI (%)

16.2 (8.7)

15.4 (9.1)

0.7 (-6.3, 7.8)

LBP history (yrs)

13.3 (10.4) 11.6 (9.9)

1.8 (-6.1, 9.7)

Intensity of LBP in last week; median (IQR)

4 (2)

5 (3)

1-3
4-10

0 (0)
3 (27.3)

0 (0)
8 (44.4)

> 10

8 (72.7)

10 (55.6)

0

9 (81.8)

12 (66.7)

1-2

2 (18.2)

3 (16.7)

Interference with normal activities; % reporting ‘yes’

5 (45.5)

8 (44.4)

Interference with recreational activities; % reporting
‘yes’

6 (54.5)

8 (44.4)

-1.7 (-6.1, 2.7)

0.7 (-2.1, 3.6)
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Table 1 Demographic and clinical characteristics of the no-LBP and CLBP groups, by gender

Episodes LBP last year; n (%)

Work days missed with last year; n (%)

3-7

3 (16.7)

8 (19.0)

19 (45.2)

8 (27.6)

12 (41.4)

Currently taking NSAID medication; % reporting ‘yes’

0 (0)

1 (2.4)

2 (6.9)

2 (6.9)

PA L3 BMC (g)

20.89 (3.39) 16.72 (3.24) 4.17 (2.05, 6.28)*

20.03
(1.93)

16.46 (3.55) 3.56 (1.17, 5.96)*

0.86 (-1.46, 3.18) 0.26 (-1.87, 2.38)
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Currently taking analgesic medication; % reporting
‘yes’

PA L3 aBMD (g/cm2)

1.13 (0.13)

1.08 (0.14)

0.48 (-0.04, 0.14)

1.11 (0.11) 1.10 (0.19)

0.02 (-0.12, 0.15)

0.02 (-0.08, 0.12) -0.01 (-0.12, 0.09)

PA total spine BMC (g)

79.07
(12.33)

61.30
(13.05)

17.77 (9.66, 25.88)*

75.79
(8.39)

12.30 (2.70, 21.88)*

3.28 (-5.46,
12.01)

PA total spine aBMD (g/cm2)

1.15 (0.12)

1.04 (0.14)

0.06 (-0.02, 0.15)

1.08 (0.10) 1.06 (0.18)

0.02 (-0.11, 0.14)

0.03 (-0.06, 0.12) -0.02 (-0.12, 0.08)

PA total spine T-score

0.08 (1.28)

-0.06 (1.27)

0.14 (-0.75, 1.03)

-0.08
(0.99)

0.32 (1.63)

-0.40 (-1.66, 0.86)

0.15 (-0.90, 1.21) -0.38 (-1.35, 0.58)

Lateral L3 BMC (g)

9.42 (1.89)

7.80 (1.74)

1.62 (0.45, 2.79)*

8.71 (1.54) 8.36 (1.64)

0.35 (-0.93, 1.62)

0.72 (-0.69, 2.12) -0.56 (-1.66, 0.54)

Lateral L3 aBMD (g/cm2)

0.82 (0.13)

0.77 (0.11)

0.06 (-0.02, 0.14)

0.74 (0.12) 0.78 (0.10)

-0.04 (-0.12, 0.04)

0.08 (-0.02, 0.18) -0.02 (-0.08, 0.05)

Lateral L3 ap.vBMD (g/cm3)

0.21 (0.03)

0.22 (0.03)

-0.01 (-0.03, 0.01)

0.20 (0.03) 0.23 (0.02)

-0.03 (-0.06, -0.01)

0.02 (-0.01, 0.04) -0.01 (-0.02, 0.01)

63.50
(13.98)

-2.20 (-10.59,
6.19)
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Table 1 Demographic and clinical characteristics of the no-LBP and CLBP groups, by gender (Continued)

*significant difference (p < 0.05)
DASS-21 21 item depression, anxiety and stress scale
ODI oswestry disability index
LBP low back pain
IQR inter-quartile range
NSAID non-steroidal anti-inflammatory drug
PA postero-anterior
BMC bone mineral content
aBMD areal bone mineral density
ap.vBMD: apparent volumetric bone mineral density
Continuous data are expressed as the mean (SD) and categorical data as the frequency (n) and proportion (%). The mean difference and 95% confidence interval (CI) are calculated within groups and between
groups for continuous data. DXA-derived parameters are unadjusted in this table
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Table 2 Results of multiple regression models for the predictor variable ‘group’ expressed for each DXA dependent
variable, adjusted for age, height and mass
Males
DXA variable
PA L3 BMC (g)
2

Females

B co-efficient (group)

95% CI

p

R2

B co-efficient
(group)

95% CI

p

R2

-0.78

-3.24, 1.68

0.52

0.11

-0.90

-2.77, 0.96

0.33

0.35#

PA L3 aBMD (g/cm )

-0.02

-0.12, 0.09

0.74

0.06

-0.02

-0.12, 0.08

0.73

0.21

PA total spine BMC (g)

-2.89

-11.97, 6.20

0.52

0.14

-0.44

-7.61, 6.73

0.90

0.37#

PA total spine aBMD (g/cm2)

-0.03

-0.13, 0.07

0.55

0.10

-0.02

-0.11, 0.07

0.71

0.26#

Lateral L3 BMC (g)

-0.71

-1.86, 0.45

0.22

0.47#

0.24

-0.81, 1.29

0.64

0.25#

0.03

#

2

Lateral L3 aBMD (g/cm )

-0.09
3

Lateral L3 ap.vBMD (g/cm )

-0.02

-1.65, -0.01
-0.04, -0.001

0.04

0.55

#

0.53

^

0.01

^

0.01

-0.06, 0.08
-0.01, 0.02

^

0.21^

^

0.16^

0.78
0.40

# multivariate model significant (p < 0.05)
^adjusted for physical activity also
PA postero-anterior
BMC bone mineral content
aBMD areal bone mineral density
ap.vBMD apparent volumetric bone mineral density
Separate models were run for males (n = 28) and females (n = 43). The unstandardized regression co-efficient (B) represents the mean difference in the DXA
variable between the groups, adjusted for the known covariates of age, height and mass with the associated 95% confidence interval (CI) and level of
significance (p). A negative B value represents a lower DXA parameter in the CLBP group. The R2 represents the proportion of variance in the DXA variables
accounted for by all the predictor variables in the model

projection DXA, independent of age, height and mass.
There are a number of mechanisms which might explain
this association, as reported recently [7], yet in this
study potential CLNP-related predictor variables of psychological wellbeing, back muscle endurance and physical activity were not associated with bone health,
suggesting that other factors may be implicated driving
this relationship. These findings raise important questions regarding the mechanisms related to, and clinical
impact of, this association and underline the potential

clinical utility of lateral-projection DXA methods to
assess vertebral bone parameters in some contexts.
However, the results presented should be interpreted
within the context of the small sample size in the study.
Although previous studies have examined the association between bone mineral measures and LBP, the relationships have been inconsistent, and are likely to be at
least partly attributable to suboptimal densitometry
methods and sites used. Other studies point to a negative association when bone mineral properties were

Figure 1 Unadjusted areal BMD (aBMD) at L3 in males with
CLBP and controls according to age.

Figure 2 Unadjusted apparent volumetric BMD (ap.vBMD) at
L3 in males with CLBP and controls according to age.

Briggs et al. BMC Musculoskeletal Disorders 2012, 13:49
http://www.biomedcentral.com/1471-2474/13/49

measured in the lumbar spine [26-29]. For example,
Bogdanffy et al [28], in a group of 15 patients (11 male)
undergoing L4-S1 spinal fusion for CLBP and lumbar
instability observed a significant mean decrease in lateral-projection aBMD at L3 of 10.1% and 11.9% at 3
and 6 months, respectively, after undergoing surgery
compared to pre-surgical values. Notably, no significant
decrease was observed for aBMD acquired using PAprojection DXA, consistent with our data.
In univariate models, vertebral DXA parameters were
not associated with potential predictor variables including
the DASS-21 subscales, back muscle endurance and vigorous physical activity (other than in females for some DXA
variables). The absence of any associations is likely attributable to the distribution of the predictor variable scores
being relatively equal between the CLBP and control
groups or insufficient power to identify any differences.
This finding suggests that other factors may be important
in explaining the association between CLBP and bone
health, such as nutrition, other aspects of physical activity
(e.g. inactivity), posture, occupation, inflammatory markers
and neuroendocrine factors. These data are somewhat
contradictory to other reports where individuals with
CLBP tend to have poorer psychological wellbeing [30],
reduced back muscle endurance [31] and reduced vigorous
physical activity [13] relative to those with no pain. The
discrepancies may be accounted for by a range of reasons.
First, there are differences in the measurement tools
between this study and earlier research. Second, the cohort
recruited for the JSHS may have predominantly adopted
active coping strategies for pain and thus experienced less
functional disability. Third, the levels of disability experienced among individuals in this cohort may have been
insufficient to significantly influence psychological wellbeing and capacity to engage in vigorous physical activity.
Fourth, the sample size was inadequate to detect small,
but clinically relevant, associations between the potential
predictor variables and the DXA parameters.
The multivariate models demonstrate that in males up
to 55% of the variance in vertebral bone mineral parameters acquired using lateral-projection DXA could be
accounted for by the combination of age, mass, height and
the presence or absence of CLBP. The adjusted mean difference in aBMD and ap.vBMD between the male groups
of 0.09 g/cm2 and 0.02 g/cm3, respectively represent 0.7
standard deviations below the raw male control group
means, or a difference of 11.0% and 9.5%, respectively,
comparable to earlier research [28]. This difference
appears to be clinically-relevant for this age group in light
of the 1.2-2.0 fold increase in the odds of sustaining a vertebral fracture with each 1.0 standard deviation decrease
in vertebral aBMD acquired through PA-projection DXA
in older men [32,33]. Further, the association between vertebral fracture risk and reduction in bone mineral
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apparent density (BMAD) acquired using a PA-scan - an
apparent volumetric measure similar to ap.vBMD used in
our study -is reported to be greater than PA-derived
aBMD [33]. Nonetheless, it is acknowledged that reliable
vertebral fracture risk estimates have not yet been determined for lateral-projection DXA parameters and therefore the biological significance remains uncertain.
The association between vertebral bone mineral measures and CLBP were only observed for those variables
measured using lateral-projection DXA. Evidence continues to emerge to substantiate the potential advantages
of lateral-projection methods, such as enhanced diagnostic
sensitivity for vertebral fracture [34] and superior predictive capacity for vertebral failure in ex situ models [35].
The lateral approach may better identify reduced bone
mineral parameters in the context of CLBP due to the
selective inclusion of the metabolically-active trabecular
bone. Moreover, age-related degenerative changes in the
lumbar spine may obscure any association with CLBP
when aBMD is measured using PA-projection methods.
No association between vertebral DXA parameters and
CLBP was observed in females. There are a number of
potential mechanisms which might explain this gender difference. Although females had lower disability scores, a
shorter LBP history, fewer episodes of LBP in the last year,
and CLBP causing less interference with recreational activities than males, these gender differences were not statistically-significant and, therefore, are unlikely to account
entirely for the absence of an association among females.
Hansson et al [29] reported that BMC measured at L3 was
negatively associated with the lifetime duration of LBP
(years since first onset), and not the severity, disability or
duration associated with the current pain episode.
Although a greater proportion of males had experienced
LBP for ≥ 20 years (27.3% vs. 16.7% in females) in our
study, this difference was not statistically significant. The
gender difference in the association between CLBP and
DXA variables could also be explained by gender-specific
neuroendocrine factors, gender differences in the extent of
intervertebral disc degeneration, a greater resilience to
musculoskeletal pain among females and other osteoporosis risk factors which were not controlled for in this study,
such as alcohol and calcium intake and inflammatory
markers.
A particular strength of this study is use of both PA-and
lateral-projection DXA modalities. Although Bogdanffy et
al [28] also used a combination of PA-and lateral-projection DXA, their study was based only on repeated measures in a single group of 15 patients undergoing spinal
fusion. To our knowledge, no other studies have used lateral-projection DXA in this context. While lateral DXA
may have potential for useful clinical applications, the associations between lateral-projection DXA parameters and
fracture risk remain largely unknown, and thus the clinical
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significance of our findings for vertebral fracture risk are
uncertain. Further, inherent limitations exist with DXA,
particularly the inability to measure true vertebral volumetric BMD - a parameter which may have demonstrated
greater deficits in trabecular BMD between the groups and indices of bone quality which are equally important as
aBMD in mediating bone strength. The association
between CLBP and bone quality is currently uncertain, yet
this may be an important area for future research, particularly in the context of inflammation-driven back disorders.
This study is also limited in the scope of measurement of
potentially important correlates of bone health. Although
vigorous physical activity was measured, the IPAQ question we used only related to activity undertaken within the
previous seven days. More extensive assessments of
volumes, frequencies and intensities of vigorous and sedentary activity may be warranted using accelerometry, given
the association between CLBP and deficits in vigorous
activity [13]. Although several exclusion criteria were
applied to this study, we were unable to account for the
potentially confounding effects of other important correlates of aBMD including nutrition, inflammatory markers,
neuroendocrine markers and other physical factors such as
posture, intervertebral disc degeneration and occupation
which may influence the association between the presence
of CLBP and aBMD. Finally, this study is limited by the
small sample size which may increase the risk of a type I
error and therefore interpretation of the results presented
should be considered within this context. Larger studies
should now be undertaken to confirm the findings from
this study.

Conclusions
CLBP in males is associated with some lumbar vertebral
BMD measures, raising important questions about the
mechanism and potential clinical impact of this
association.
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